Healthcare / Medical Care FacilitiesNasdaqCM
$128.02
-1.09 (-0.84%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 32% · confianza 25%
FCF escenarios
weak_data · normalized FCF $20.8M · quality 44.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
58/100
C
Piotroski
7/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$881M
P/E
9.4x
↓EV/EBITDA
3.6x
↓ROE
21.5%
↑Gross Margin
50.8%
↑Debt/Equity
1.07
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2010–2025 · 15 años de histórico normalizado
Revenue CAGR
+58.5%
FCF CAGR
—
FCF margin
28.1%
FCF / Net income
3.47x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $875.3M · net income $70.8M · FCF $245.6M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||||||
| Revenue | $875.3M | $875.3M | $479.9M | $247.6M | $219.3M | $331.5M | $274.0M | $1.4M | $1.4M | $23166.00 | $0.00 | $474679.00 | $1.1M | $1.5M | $1.6M | $1.8M | $874774.00 |
| Net Income | $70.8M | $70.8M | $52.1M | $-45.8M | $-424.8M | $132.6M | $106.0M | $-7.1M | $-950129.00 | $582062.00 | $-7.4M | $83809.00 | $-684342.00 | $250489.00 | $-1.6M | $-383393.00 | $158137.00 |
| EBITDA | $287.5M | $287.5M | $148.7M | $-14.6M | $-394.0M | $177.9M | $159.1M | $-6.7M | $-837713.00 | — | — | — | $-660182.00 | $-687131.00 | — | — | — |
| EPS | 10.48 | 10.48 | 9.71 | -10.50 | -100.50 | 33.00 | 27.00 | — | — | — | — | — | — | — | — | — | — |
| Gross Margin | 50.8% | 50.8% | 40.9% | 14.0% | 7.0% | 54.1% | 57.5% | 39.2% | 62.9% | -31.6% | — | 98.3% | 56.5% | 66.1% | 50.8% | 57.1% | 55.2% |
| Operating Margin | 31.5% | 31.5% | 28.7% | -0.6% | -2.1% | 51.4% | 55.9% | -504.8% | -61.5% | -24574.5% | — | -112.3% | -67.7% | -49.8% | -98.7% | -47.3% | -153.9% |
| Net Margin | 8.1% | 8.1% | 10.9% | -18.5% | -193.7% | 40.0% | 38.7% | -520.8% | -69.5% | 2512.6% | — | 17.7% | -64.0% | 17.1% | -101.9% | -21.5% | 18.1% |
| Balance Sheet | |||||||||||||||||
| Debt/Equity | 1.07 | 1.07 | 2.57 | 4.49 | 2.79 | 0.69 | 0.00 | 0.00 | -0.20 | — | — | — | — | — | — | — | — |
| Current Ratio | 3.14 | 3.14 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | |||||||||||||||||
| Free Cash Flow | $245.6M | $245.6M | $20.8M | $-8.2M | $36.0M | $136.5M | $25.5M | $-4.1M | $-480049.00 | — | — | $46704.00 | $161228.00 | — | $-510630.00 | $-639745.00 | $-1.6M |
| Returns | |||||||||||||||||
| ROE | 21.5% | 21.5% | 39.3% | -74.5% | -443.1% | 115.6% | -9346.5% | -382.9% | 63.5% | -58.4% | 126.6% | 5.4% | — | — | — | — | — |
| Valuation | |||||||||||||||||
| P/E | 9.37 | 9.37 | 3.49 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EV/EBITDA | 3.58 | 3.58 | 3.24 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| P/B | 2.63 | 2.63 | 1.37 | 2.24 | 11.51 | — | — | — | — | — | — | — | — | — | — | — | — |
| Growth & Yield | |||||||||||||||||
| Revenue Growth | 82.4% | 82.4% | 93.8% | 12.9% | — | 21.0% | 19954.5% | -0.0% | 5800.9% | — | -100.0% | -55.6% | -26.9% | -8.3% | -10.7% | 103.9% | — |
| EPS Growth | 7.9% | 7.9% | 192.5% | 89.6% | — | 22.2% | — | — | — | — | — | — | — | — | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
2.7%
EPS terminal req.
$11.36
Spread vs growth
5.2%
5Y implied EPS CAGR
5.6%
EPS terminal req.
$13.75
Spread vs growth
2.4%
10Y implied EPS CAGR
7.8%
EPS terminal req.
$22.14
Spread vs growth
0.2%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-23.7%
Start / end P/E
17.3x → 12.2x
EPS bridge
9.71 → 10.48
Residual
-2.3%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.